Search

everythinglearnresearchcommunity

for

Search:↓

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Papillon-Lefèvre Syndrome causes early tooth loss and skin issues, needing early dental diagnosis.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The symposium concluded that understanding the molecular mechanisms of skin aging could lead to better clinical practices and treatments.

Hair from different ethnic groups affects soil nutrient release differently.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Sarcoidosis can cause severe high calcium levels, hair loss, and kidney failure.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

Experts advise using sunscreen and proper skin care before, during, and after procedures to speed healing, prevent complications, and reduce scarring.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Setipiprant did not significantly improve hair growth in men with hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Using powdered umbilical remnant allograft can effectively treat chronic scalp wounds resistant to traditional treatments.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Goat hair shows changes in metal levels and stress when goats move from indoors to mountain pastures.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

The symposium highlighted the skin's role in sensing itch, pain, touch, and pleasure, and discussed new research and techniques for understanding and treating these sensations.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.